Tiba Aynechi

Senior Partner at Novo Ventures (US), Inc.

Tiba Aynechi

Tiba Aynechi

Senior Partner at Novo Ventures (US), Inc.

Overview
RelSci Relationships

504

Number of Boards

13

Birthday

1976

Age

44

Relationships
RelSci Relationships are individuals Tiba Aynechi likely has professional access to. A relationship does not necessarily indicate a personal connection.

Post Doctorate, Department of Organic Chemistry at Yale University

Relationship likelihood: Strong

Co-Founder at Mirum Pharmaceuticals, Inc.

Relationship likelihood: Strong

Partner at TPG Growth LLC

Relationship likelihood: Strong

Managing Partner at Pivotal Bioventure Partners Investment Advisor LLC

Relationship likelihood: Strong

Managing Partner at LR Management Company LLC

Relationship likelihood: Strong

Founder at Avalyn Pharma, Inc.

Relationship likelihood: Strong

Managing Director at Vivo Capital LLC

Relationship likelihood: Strong

Venture Partner at Pappas Capital LLC

Relationship likelihood: Strong

Partner at Novo Ventures 1 A/S

Relationship likelihood: Strong

Managing Partner at Novo Ventures (US), Inc.

Relationship likelihood: Strong

Paths to Tiba Aynechi
Potential Connections via
Relationship Science
You
Tiba Aynechi
Senior Partner at Novo Ventures (US), Inc.
Education
Undergraduate Degree in Physics

University of California, Irvine is a public research university located in Irvine, California and one of the 10 general campuses in the University of California (UC) system. UCI's Orange County campus is the fifth-largest in the UC system. UC Irvine is considered a Public Ivy and became a member of the Association of American Universities in 1996, and is the youngest university to hold membership. It also administers the UC Irvine Medical Center, a large teaching hospital; the UC Irvine Health Sciences system in the City of Orange; the University of California, Irvine, Arboretum; and a portion of the University of California Natural Reserve System.

PhD, Graduate Group in Biophysics

The University of California, San Francisco (UCSF), is a center of health sciences research, patient care, and education; located in San Francisco, California. UCSF is widely regarded as one of the world's leading universities in health sciences. Though one of the 10 campuses of the University of California, it is unique for being the only University of California campus dedicated solely to graduate education, and in health and biomedical sciences. Some of UCSF's treatment centers include kidney transplants and liver transplantation, radiology, neurosurgery, neurology, oncology, ophthalmology, gene therapy, women's health, fetal surgery, pediatrics, and internal medicine.

Career History
Senior Partner
2010 - Current

Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world.

Research Associater
1995 - 1998

University of California, Irvine is a public research university located in Irvine, California and one of the 10 general campuses in the University of California (UC) system. UCI's Orange County campus is the fifth-largest in the UC system. UC Irvine is considered a Public Ivy and became a member of the Association of American Universities in 1996, and is the youngest university to hold membership. It also administers the UC Irvine Medical Center, a large teaching hospital; the UC Irvine Health Sciences system in the City of Orange; the University of California, Irvine, Arboretum; and a portion of the University of California Natural Reserve System.

Director
2006 - 2010

Burrill LLC invests in companies located in the US and Europe. The firm makes investments in human healthcare therapeutics and diagnostics/devices, health/wellness, agricultural biotechnology, biofuels, industrial biotechnology, biomaterials and bioprocesses with an investment size ranging from $5 million to $15 million. They provide financing for It provides financing for early and later stage capital requirements, acquisitions, and divestitures.

Boards & Committees
Member, Board of Directors
2019 - Current
Member, Board of Directors
2018 - Current

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz on May 7, 2018 and is headquartered in Foster City, CA.

Director
2017 - Current

Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. Our lead asset is inhaled pirfenidone (AP01) for the treatment of IPF. With offices in Seattle and San Diego, Avalyn's experienced clinical and inhaled product development team is rapidly advancing AP01 for the treatment of IPF and additional pipeline candidates for IPF and other severe respiratory diseases.

Transactions
Details Hidden

Merit Medical Systems, Inc. purchases Cianna Medical, Inc. from Fog City Management LLC, Windamere Venture Partners LLC, Saints Ventures LLC, EMP Management, LLC /CA, Novo Ventures 1 A/S

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Tiba Aynechi. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Tiba Aynechi's profile does not indicate a business or promotional relationship of any kind between RelSci and Tiba Aynechi.